Page last updated: 2024-11-01

ondansetron and Burns

ondansetron has been researched along with Burns in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.

Research Excerpts

ExcerptRelevanceReference
"Post-burn pruritus is the pruritus that occurs after burn during the rehabilitation and healing process of burn wounds."2.66Post-Burn Pruritus. ( Chung, BY; Jung, MJ; Kang, SY; Kim, HB; Kim, HO; Kwak, IS; Park, CW, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Al-Khalil, M1
Sack, A1
Elson, R1
Pleat, J1
Chung, BY1
Kim, HB1
Jung, MJ1
Kang, SY1
Kwak, IS1
Park, CW1
Kim, HO1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns[NCT06104540]24 participants (Anticipated)Interventional2023-11-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for ondansetron and Burns

ArticleYear
Post-Burn Pruritus.
    International journal of molecular sciences, 2020, May-29, Volume: 21, Issue:11

    Topics: Animals; Antipsychotic Agents; Burns; Gabapentin; Histamine Antagonists; Humans; Inflammation; Kerat

2020

Other Studies

1 other study available for ondansetron and Burns

ArticleYear
A 5-year single-centre retrospective study of potential drug interactions in burns inpatients with psychiatric comorbidities.
    Burns : journal of the International Society for Burn Injuries, 2020, Volume: 46, Issue:5

    Topics: Adult; Analgesics, Opioid; Antidepressive Agents; Arrhythmias, Cardiac; Burns; Comorbidity; Drug Int

2020